Product Information
KETOCONAZOLE 2% CREAM is a generic product labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., priced at $0.2848 per GM under NDC 00168009915. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Apr 28, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/g
NDC
00168009915
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
KETOCONAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA076294FDA Approved
4/28/2004
TE Code
AB
On Market Since
4/28/2004
Pharmacological Classes
Price Statistics
The NADAC for KETOCONAZOLE 2% CREAM has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 4.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2848 per GM |
|---|---|
| All-time high | $1.9185 (Jan 13, 2016) |
| All-time low | $0.2119 (Jul 17, 2024) |
| 52-week high | $0.3514 |
| 52-week low | $0.2848 |
| Median price | $0.6325 |
| Average price | $0.7125 |
| Largest weekly change | +69.4% (Jun 11, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 43% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ketoconazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KETOCONAZOLE 2% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for KETOCONAZOLE 2% CREAM, manufactured by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., is $0.2848 per GM (NDC 00168009915), effective Sep 30, 2026.
How has the price of KETOCONAZOLE 2% CREAM changed over time?
Over the history we have for it, the NADAC for KETOCONAZOLE 2% CREAM has declined 4.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for KETOCONAZOLE 2% CREAM?
Since Nov 28, 2013, the NADAC for KETOCONAZOLE 2% CREAM has ranged from a low of $0.2119 (Jul 17, 2024) to a high of $1.9185 (Jan 13, 2016), with a median of $0.6325 per GM.
Are there cheaper alternatives to KETOCONAZOLE 2% CREAM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, KETOCONAZOLE 2% CREAM, is $0.1622 per GM — about 43% below KETOCONAZOLE 2% CREAM.
Who manufactures KETOCONAZOLE 2% CREAM?
KETOCONAZOLE 2% CREAM (NDC 00168009915) is labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., and CMS classifies it as a generic product.